Circulating tumour-cell count used to decide between treatments for breast cancer patients
Circulating tumour-cell count used to decide between treatments for breast cancer patients
The combined analysis of carfilzomib trials for multiple myeloma
Researchers identify mutation that causes resistance to venetoclax in CLL patients
Resistance mechanisms to venetoclax in patients with progressive CLL
Determining the prognosis of patients with myelodysplastic syndromes using machine learning
Link between gut microbiota and haematopoietic cell transplantation outcomes
Initial report of the Beat AML umbrella study for previously untreated AML
Diversity of gut microbiota linked with complications from haematopoietic cell transplantation
The value for money of drugs and other tech
What is the 'HARMONY Data Platform'?
New data and analytics from HARMONY
The importance of big data for blood cancer